Christopher T. Griffith

Top rated Intellectual Property Litigation attorney in Chicago, Illinois

Green, Griffith & Associates LLP
Christopher T. Griffith
Green, Griffith & Associates LLP

Practice Areas: Intellectual Property Litigation, Intellectual Property; view more

Licensed in Illinois since: 1988

Education: University of Houston Law Center

Selected to Super Lawyers: 2016 - 2024

Green, Griffith & Associates LLP

20 N Clark St
Suite 3300
Chicago, IL 60602 Visit website

Details

Christopher T. Griffith is a founding partner of the law firm Green, Griffith & Associates LLP.  He leverages over 35 years of experience in handling all types of intellectual property (IP) matters, with specific expertise in litigation.  As a member of the Northern District of Illinois Trial Bar, he serves as local and co-counsel in patent cases.

Mr. Griffith spent his career supporting clients in the medical, chemical, pharmaceutical and biotechnological fields.  This has helped him obtain a holistic understanding of the business objectives of his clients, which has aided him in providing them with strategic counsel and practical strategies. 

His extensive knowledge in the field of IP law has enabled him to extend his services to the preparation and prosecution of US and foreign patent applications, trademarks, copyrights, the development and management of portfolios, providing opinions (e.g., freedom-to-operate), and guidance on the legal aspects of product development and protection.  He also advises corporations and investors in the areas of risk assessment and other valuation topics.

Mr. Griffith has particular experience handling issues concerning the Food and Drug Administration, such as the Orange Book and the Hatch-Waxman Act, along with others under the Biologics Price Competition and Innovation Act.  In addition to his court room experience, he is also experienced in arbitration and mediation, and attends to inter partes reviews and post-grant proceedings under the American Invents Act. 

Mr. Griffith received a masters degree in biotechnology enterprise and entrepreneurship from The Johns Hopkins University, and holds a bachelors degree in chemical engineering.  He graduated with his J.D.  from the University of Houston, where he was Editor-in-Chief of the Houston Journal of International Law. 

Mr. Griffith is admitted in Illinois, Texas, the U.S. Court of Appeals for the Federal Circuit, the U.S. District Court for the Northern District of Illinois (Member, Trial Bar), and the U.S. Patent and Trademark Office (Reg. No. 33,392).

As an adjunct professor, Mr. Griffith designed and taught a course in patent law at the University of Illinois Chicago School of Law for over 15 years. In addition, he prioritizes giving back to the community and engages in pro bono services and volunteering programs at the Chicago Lawyers’ Committee for Civil Rights and the U.S. District Court for the Northern District of Illinois’ Pro Bono Program.

Practice areas

Intellectual Property Litigation, Intellectual Property

Focus areas

Copyrights, Intellectual Property Law, Patents, Trademarks

  • 70% Intellectual Property Litigation
  • 30% Intellectual Property

First Admitted: 1988, Illinois

Professional Webpage: https://www.greengriffith.com/team/christopher-t-griffith/

Educational Background:
  • Masters in Biotechnology Enterprise and Entrepreneurship, Johns Hopkins University
  • BS, Chemical Engineering (including Biomedical Engineering courses), Michigan State University
Bar/Professional Activity:
  • Adjunct Professor, University of Illinois Chicago School of Law, Chicago, IL (JD and Masters Level Courses in Patent Law), 2002-2016
Scholarly Lectures/Writings:
  • Inter Partes Review, Litigation or Both: Strategic Considerations for Pharmaceutical Companies,” 9th Annual Pharma IPR Conference, Mumbai, India, March 2020; “Biosimilars in US, EU and China: Where Are We Now and Where Are We Going?” 4th China Pharma IP Summit 2019, Shanghai, China, October 2019; “Section 101: Analysis of Recent Developments and Proposed Legislation,” International IP Skills Summit (IIPSS), Hyderabad, India, August 2019; “Patent Fundamentals Bootcamp 2019: An Introduction to Patent Drafting, Prosecution, and Litigation,” Moderator and Faculty Member, Practising Law Institute, Chicago, IL, May 2019; “Recent US Legal Developments Affecting Pharma-Related Contentious Matters,” 8th Annual Pharma IPR Conference, Mumbai, India, March 2019; “Navigating the IP Waters – Portfolio Development, FDA Exclusivities and Current Legal Issues Affecting the Journey Toward Commercialization of Biopharmaceutical Products in the US,” Asia Pharma R&D Leaders, Beijing, China, January 2019; “US Patent Litigation Trends: Past, Present and Future,” IIPLA 5th Dubai IP Congress, Dubai, UAE, January 2019;  “IP in the Courts: The Latest in IP Litigation,” World Intellectual Property Forum 2018 (WIPF), New Delhi, India, November 2018; “Navigating the IP/FDA Exclusivity Waters – Recent Developments Affecting the Journey to 505(b)(1), 505(b)(2), ANDA and Biologics Approval in the US,” 3rd Annual China Pharma IP Summit, Beijing, China, October 2018;  "Paragraph IV Litigation Trends, Analysis and Future Predictions" and "Strategic Considerations Concerning Inter Partes Reviews (IPRs) - Appearing in Dual Proceedings Before the U.S. District Court and PTAB," 3rd International IP Skills Summit (IIPSS), Hyderabad, India, June 2018;  “Interplay Between FDA Exclusivity, PTAB/IPRs and Hatch-Waxman Litigation on the Filing and Approval of 505(b)(2) and ANDA Applications,” 8th Annual Generic International Summit Asia, Shanghai, China, April 2018; “Latest Developments: Federal Courts and PTAB,” 7th Annual Pharma IPR Conference, Mumbai, India, March, 2018; “505(b)(2) NDAs v. ANDAs: Case Studies and Implications for Patent Portfolio Development and US Litigation,” 2nd China Pharma IP Summit 2017, Shanghai, China, December 2017; “Exploring New Developments in the Law of Divided and Inducement Infringement and Its Continuing Impact on Paragraph IV Litigation,” Paragraph IV Disputes Master Symposium, Chicago, IL, October 2017; “Selected U.S. Patent Law Topics Relevant to Pharmaceutical and Biotech Practice (Patentability, Validity and Infringement),” Advanced Training Seminars for the All-China Patent Agents Association, Chicago, IL, September 2014, July and November 2013; "Current Issues and Strategies in U.S. Patent Prosecution,” Advanced Training Seminar for Patent Reexaminers of the People’s Republic of China (SIPO), Chicago, IL, June and October 2013; “Selected U.S. Patent Law Topics Relevant to Pharmaceutical and Biotech Practice (Patentability, Validity and Infringement),” Advanced Training Seminars for the All-China Patent Agents Association and State Intellectual Property Organization (SIPO), Chicago, IL, May, September and October 2012; “Patent Litigation Issues in the Context of Biotechnology and Pharmaceutical Patents,” Advanced Training Seminar for the All-China Patent Agents Association, Chicago, IL, June and September 2011; U.S. Patent Law and Pharmaceuticals--Current and Future Trends, February, 2008 (Mumbai, India); October 2007: Current Issues and Strategies in U.S. Patent Prosecution: Advanced Training Seminar for Patent Reexaminers of the People's Republic of China (Chicago, Illinois); February 2007:  Recent Developments in U.S. Patent Law Affecting the Pharmaceutical Industry, Global Generic Pharmaceutical Conference 2007 (Mumbai, India); December 2006: Patent Considerations in the Pharmaceutical Industry, 58th Indian Pharmaceutical Congress (Mumbai, India); October 2006: Current Issues and Strategies in U.S. Patent Prosecution: Advanced Training Seminar for Patent Reexaminers of the People's Republic of China (Chicago, Illinois); June 2006:  Patent Barriers to Generic Pharmaceutical Entry, AIPLA Road Shows (Boston, Houston, San Jose); March 2006: The Changing Landscape of U.S. Patent Law, Global Generic Pharmaceutical Conference 2006 (Mumbai, India); October 2005:  Patent Issues and Trends In Cosmetic Formulations, Society of Cosmetic Chemists (Chicago); March 2003 & 2004:  Due Diligence in IP Business Transactions, Practicing Law Institute (Chicago) September, 2002; "Senate Passes Bill Revising Hatch-Waxman Framework for Generic Drug Approval," Regulatory Affairs FOCUS (Regulatory Affairs Professionals Society) March 2001;  Presentation on Process Patents, National Association of Pharmaceutical and Manufacturers Bulk Drug Workshop (New York City) January 2000;  Presentation on Process Patents and Related Issues, National Association of Pharmaceutical Manufacturers Annual Meeting (San Juan, Puerto Rico) 1999; Presentations on patent law (patentability/freedom-to-operate/opinions) to client R&D teams
Special Licenses/Certifications:
  • Texas (Admitted and Active) - Bar No. 24122711
  • U.S. Court of Appeals for the Federal Circuit; U.S. District Court for the Northern District of Illinois (Member, Trial Bar); U.S. District Court for the District of Arizona; U.S. District Court for the District of Columbia; U.S. District Court for the District of Delaware; U.S. District Court for the Southern District of Florida; U.S. District Court for the Northern District of Georgia; U.S. District Court for the District of Nevada; U.S. District Court for the District of New Jersey; U.S. District Court for the Southern District of New York; U.S. District Court for the Northern District of Ohio; U.S. District Court for the Eastern District of Pennsylvania; U.S. District Court for the Western District of Washington; Registered Patent Attorney, U.S. Patent and Trademark Office, No. 33,392 (list includes pro hac vice admissions).
Pro bono/Community Service:
  • Pro bono representation in several federal court actions, e.g., prisoner seeking remedy for improper healthcare, individual alleging race-based discrimination and improper termination by employer, individual alleging race-based improper termination.
Honors/Awards:
  • Selected as a “Life Sciences Star,” LMG Life Sciences
  • Named as an “IP Star,” Managing IP
  • Listed in Intellectual Asset Management's (IAM) Patent 1000 in Litigation
  • Selected by peers as a “Leading Lawyer” in Intellectual Property Law – Leading Lawyers Network
  • Recognized by Illinois Super Lawyers in Intellectual Property Litigation
  • Listed among the “Top Lawyers in Illinois” in Intellectual Property Law – Chicago Lawyer
Industry Groups:
  • Biologics
  • Biotechnology
  • Chemistry
  • IP-Focused Businesses
  • Life Sciences
  • Medical Devices
  • Pharma
  • Start-ups

Office location for Christopher T. Griffith

20 N Clark St
Suite 3300
Chicago, IL 60602

Phone: 312-883-8008

Selections

9 Years Super Lawyers
  • Super Lawyers: 2016 - 2024

Additional sources of information about Christopher T. Griffith

Attorney resources for Christopher T. Griffith

Page Generated: 0.10048604011536 sec